Skip to main content

Table 3 Relationships between co-expression of TLR4/MyD88 signaling pathway proteins and clinicopathologic factors

From: Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers

 

TLR4/MyD88

 

TLR4/MyD88/NF-κB

 

Positive

Negative

P

Positive

Negative

P

Histologic type

Serous

12

48

0.000

10

50

0.002

 

Mucinous

2

23

 

1

24

 
 

Endometrioid

2

9

 

2

9

 
 

Clear cell

13

12

 

12

13

 
 

Undifferentiated

2

0

 

1

1

 

Histologic grade

Grade 1

4

31

0.074

3

32

0.058

 

Grade 2

20

42

 

18

44

 
 

Grade 3

7

19

 

5

21

 

Tumor size

<10 cm

17

44

0.539

13

48

0.569

 

≥10 cm

14

48

 

13

49

 

Mitotic count

<10/10HPFs

10

40

0.415

9

41

0.707

 

10 ≤ but < 20/10HPFs

14

30

 

11

33

 
 

≥20/10HPFs

7

22

 

6

23

 

FIGO stage

I/II

10

52

0.023

8

54

0.028

 

III/IV

21

40

 

18

43

 

Disease recurrence

No

13

49

0.305

11

51

0.384

 

Yes

18

43

 

15

46